Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
BB MEDTECH AG (VTX:MEDN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
At the Extraordinary General Meeting that took place today, the shareholders of BB MEDTECH AG approved the proposal of the Board of Directors to cancel 1 450 000 shares that were acquired during the course of the third share buy-back program. As a result of this, the share capital will be reduced from CHF 29 000 000 to CHF 26 100 000.
It was also decided to carry out a fourth share buy-back program in order to limit the discount of BB MEDTECH in a sustained manner and to reduce it further. In accordance with the proposed share buy-back program, up to 10% of treasury shares, i.e. up to 1 305 000 shares, can be redeemed via a second trading line on the SIX Swiss Exchange. At one of the forthcoming General Meetings, the Board of Directors will propose a capital reduction that is equivalent to the volume of shares redeemed. The share buy-back will take place on November 17, 2008 and will continue until no later than November 16, 2011. Details of the share buy-back program will be published in the "Neue Zürcher Zeitung" and "Le Temps", as well as on the company's website, www.bbmedtech.com.
Swiss Valor/ISIN number/Ticker symbol: Registered shares in BB MEDTECH with a nominal value of CHF 2 each 3839001 / CH0038390016 / MEDN
Registered shares in BB MEDTECH with a nominal value of CHF 2 each (share buy-back - second trading line) 2 605 089 / CH0026050895 / MEDEE
For further information, please contact: Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht/Zurich Michael Hutter, Tel. +41 44 267 67 00
--- End of Message ---
BB MEDTECH AG Vordergasse 3 Schaffhausen Switzerland
